Cyrus Biotechnology
Seattle, United States · Founded 2014 · $26.9M raised
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- cyrusbio.com
- Total Funding
- $26.9M
- Last Round
- $18.0M Series BDec 2021
- Rounds
- 3
About
Cyrus Biotechnology is a computationally-driven biologics company re-engineering existing proteins for serious unmet medical needs.
Summary
Cyrus Biotechnology is a Biotech company based in Seattle, United States, founded in 2014. It has raised $26.9M in total across 3 rounds, most recently a $18.0M Series B round in Dec 2021. Investors include Quiet Capital, Trinity Ventures and OrbiMed.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...